CLINICAL TRIALS PROFILE FOR VAFSEO
✉ Email this page to a colleague
All Clinical Trials for VAFSEO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT06520826 ↗ | Vafseo Outcomes In-Center Experience | RECRUITING | Akebia Therapeutics | PHASE3 | 2024-11-20 | This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD). This study will obtain long-term safety data in a large sample of subjects receiving in-center hemodialysis to support adoption of three times per week vadadustat dosing. |
| NCT06520826 ↗ | Vafseo Outcomes In-Center Experience | RECRUITING | USRC Kidney Research | PHASE3 | 2024-11-20 | This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD). This study will obtain long-term safety data in a large sample of subjects receiving in-center hemodialysis to support adoption of three times per week vadadustat dosing. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VAFSEO
Condition Name
Clinical Trial Locations for VAFSEO
Trials by Country
Clinical Trial Progress for VAFSEO
Clinical Trial Phase
Clinical Trial Sponsors for VAFSEO
Sponsor Name
